Efficacy of Neural Prolotherapy for Treatment of Anserine Bursitis "NPCAB"
Status:
Completed
Trial end date:
2019-10-30
Target enrollment:
Participant gender:
Summary
Anserine bursitis is a common etiology of medial knee pain. It could be severe enough to
limit the patient's functional abilities with affection of the quality of life. The etiology
of AB is unknown. It could be bursitis, tendinitis or other unknown etiology.
The treatment of AB includes conservative and surgical treatment. Conservative treatment
consists of non-pharmacologic treatment and pharmacologic treatment. Local corticosteroid
injection is a treatment for refractory chronic anserine bursitis.
Neural prolotherapy is the subcutaneous perineural injection of isotonic dextrose 5% in water
solution at the fascial penetration point of the sensory nerve where it reaches the
subcutaneous plane and along its course. It can be used for the treatment of chronic anserine
bursitis.
This study aimed to determine the efficacy of neural prolotherapy subcutaneous perineural
injection versus corticosteroid local soft tissue injection therapy for relieving pain and
improvement of function among patients with chronic anserine bursitis.